Statistical methods in women's health & pregnancy trials
The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.
ANCOVA
Non-inferiority trial design
Mixed-effects model
Hazard ratio
Multiple imputation / missing data
Cochran-Mantel-Haenszel test
Odds ratio
Logistic regression
All women's health & pregnancy trials
790 results
- Pregabalin for the Treatment of Vulvodynia: Complete Statistical AnalysisIndependent statistical analysis of Pregabalin for the Treatment of Vulvodynia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00853229).
- Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Preliminary Performance Study of the New TIPI Device in the Prevention of Stress Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02955394).
- Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: Complete Statistical AnalysisIndependent statistical analysis of Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PRESERVEIndependent statistical analysis of the randomized phase 3 PRESERVE trial evaluating intravenous sodium bicarbonate versus saline and oral N-acetylcysteine versus placebo for serious patient-centered events following angiography.
- PRESERVEIndependent statistical analysis of Prevention of Serious Adverse Events Following Angiography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01467466).
- Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.: Complete Statistical AnalysisIndependent statistical analysis of Presurgical Treatment With Letrozole in Patients With Early-stage Breast Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02010021).
- PREVENTIndependent statistical analysis of Improving Patient Prioritization During Hospital-homecare Transition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04136951).
- Preventing Sickle Cell Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of Preventing Sickle Cell Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02373241).
- Prevention of Acute Kidney Injury in Cardiac Surgery Patients: Complete Statistical AnalysisIndependent statistical analysis of Prevention of Acute Kidney Injury in Cardiac Surgery Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00921518).
- Previously Implanted Pudendal Nerve Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Previously Implanted Pudendal Nerve Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04473469).
- Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00203502).
- ProACTIndependent statistical analysis of ProACT Therapy for the Treatment of Stress Urinary Incontinence in Males: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- PROBIOLACIndependent statistical analysis of Global Effects of a Probiotic Strain on Lactating Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01124448).
- Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor: primary endpoint results, effect estimate with confidence…
- ProDiuSIndependent statistical analysis of Protocolized Diuretic Strategy in Cardiorenal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01921829).
- Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: Complete Statistical AnalysisIndependent statistical analysis of Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: Complete Statistical AnalysisIndependent statistical analysis of Prone Partial Breast Irradiation (PBI): a Prospective Randomized Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02276885).
- Prophylactic Methylergonovine for Twin Cesarean: Complete Statistical AnalysisIndependent statistical analysis of Prophylactic Methylergonovine for Twin Cesarean: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05772156).
- Prostatic Urethral Lift in Subject With Acute Urinary Retention: Complete Statistical AnalysisIndependent statistical analysis of Prostatic Urethral Lift in Subject With Acute Urinary Retention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03194737).
- PROTECtIndependent statistical analysis of A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00579995).
- Protocol for Women at Increased Risk of Developing Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Protocol for Women at Increased Risk of Developing Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00291135).
- Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: Complete Statistical AnalysisIndependent statistical analysis of Proton Radiation Therapy for Invasive Breast Cancer Following Mastectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01340495).
- PTNS-MIndependent statistical analysis of Posterior Tibial Nerve Stimulation (PTNS) Plus Mirabegron to Treat Refractory OAB Symptoms (PTNS-M Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: Complete Statistical AnalysisIndependent statistical analysis of Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients: Complete Statistical AnalysisIndependent statistical analysis of Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Quantitative Transmission Imaging Compared With MRI as Supplemental Screening for High Lifetime Risk of Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: Complete Statistical AnalysisIndependent statistical analysis of QUILT-3.040: ETBX-011 (Ad5 [E1-, E2b-]-CEA(6D)) Vaccine in Combination With ALT-803 (Super-agonist IL-15) in Subjects Having CEA-Expressing Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- R21Independent statistical analysis of Early Menopause Hormone Treatment and Cognition: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046643).
- RADAR-AIndependent statistical analysis of Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study A: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer: Complete Statistical AnalysisIndependent statistical analysis of Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Randomized Phase II Study of Preoperative Letrozole (Femara) in Combination With Avastin in Hormone Receptor Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: Complete Statistical AnalysisIndependent statistical analysis of Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm: Complete Statistical AnalysisIndependent statistical analysis of Randomized Study Of Novel Enuresis Alarm vs Standard Bedwetting Alarm: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05214131).
- Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Randomized Translational Study to Examine the Effects of Shared Care in Management of Gestational Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Randomized Trial for Botox Urinary Incontinence: Complete Statistical AnalysisIndependent statistical analysis of Randomized Trial for Botox Urinary Incontinence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178191).
- Rapid Diagnostic Assay for Gonorrhea and Chlamydia: Complete Statistical AnalysisIndependent statistical analysis of Rapid Diagnostic Assay for Gonorrhea and Chlamydia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05564299).
- Re-expression of ER in Triple Negative Breast Cancers: Complete Statistical AnalysisIndependent statistical analysis of Re-expression of ER in Triple Negative Breast Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01194908).
- REAL-ICUIndependent statistical analysis of Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor: Complete Statistical AnalysisIndependent statistical analysis of Real-World Effectiveness of Palbociclib in Combination With an Aromatase Inhibitor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05361655).
- Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy: Complete Statistical AnalysisIndependent statistical analysis of Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176354).
- REALITY PlusIndependent statistical analysis of REALITY Plus (NCT03395821), a randomized trial comparing conventional training with virtual reality plus conventional training for surgical skills in ObGyn residents.
- Recall by Genotype: Neuropeptide Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Recall by Genotype: Neuropeptide Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05901467).
- RECIAIndependent statistical analysis of Multifactorial Approach to Emergent Cerclage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01114516).
- RECORD-4Independent statistical analysis of Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01491672).
- Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: Complete Statistical AnalysisIndependent statistical analysis of Recurrent Bacterial Vaginosis and Vaginal Acidifying Gel Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00545181).
- Reducing Adolescent Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Reducing Adolescent Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04120376).
- Reducing Metabolic Syndrome Among Breast Cancer Survivors: Complete Statistical AnalysisIndependent statistical analysis of Reducing Metabolic Syndrome Among Breast Cancer Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03719677).